about
Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical ReviewEvaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trialLeydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature.Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literatureBile acids: from digestion to cancers.Cholesterol and male fertility: what about orphans and adopted?Development of a cross-disciplinary continuous insulin infusion protocol for non-critically ill patients in a French university hospital.Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system.Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.Infundibuloneurohypophysitis Associated With Sjögren Syndrome Successfully Treated With Mycophenolate Mofetil: A Case Report.Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology.Identification of the Functions of Liver X Receptor-β in Sertoli Cells Using a Targeted Expression-Rescue Model.Cymbopogon citratus and Cymbopogon giganteus essential oils have cytotoxic effects on tumor cell cultures. Identification of citral as a new putative anti-proliferative molecule.Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis.[Challenges in the management of amiodarone-induced thyrotoxicosis]Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after studyLiver X Receptors: A Possible Link between Lipid Disorders and Female Infertility.Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomideEnolase is regulated by Liver X ReceptorsProstate adenocarcinoma in a young patient with multiple endocrine neoplasia 2BCholesterol: A Gatekeeper of Male Fertility?LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?Issues in amiodarone-induced thyrotoxicosis: Update and review of the literatureStimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid CancersAge, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients
P50
Q26774749-C19C24C4-3CD0-432A-9A7C-DAD00E584EEBQ33965084-80BBA0F8-2491-4FA4-BDF3-66BCB3260A88Q35834608-30F667B5-BC1C-43C7-8CC5-86B2AB0ECDF6Q37467757-122B0B3B-0BFC-4B25-A171-0BB1F5994F12Q37646677-A85CF550-4974-4812-A1DB-8E86F8DECC7DQ38024178-B86463B0-9888-4688-8BE7-8E66ACA82CD4Q38024187-BBA296D2-E813-4AE2-A651-9C1D5012F5A6Q38725471-EBB855F4-0B2B-4C58-85A7-C608800A5D29Q38811342-CA556FF1-9CB7-4967-907D-CF950209CAC9Q40924154-CB290048-AD2C-4B2D-809B-5DF6B822DD7CQ41155963-8E8AF0C9-CC5C-4B67-8800-AD2EF097AD53Q46621063-6E2AF5EB-A465-4BCB-97AD-B252FAC094CFQ48074060-37CD3E1D-19A9-48C8-A894-9AE20B5840F0Q52675904-6864FF1D-03E0-4920-BC9C-1B3079128C13Q54982115-B46368D1-46BF-4BBF-99C4-37EECB30C9ACQ57067591-EAF9453E-9A5C-4046-BFA5-4591BDA14D22Q61808501-DDFEB0C7-7F43-4438-8EA4-F924C7045C06Q64884005-30EC7AF3-B458-4B72-8B82-2286FA8F2C4CQ86343171-816D641A-9503-47FA-8FA4-06EB83B558BAQ86814204-ADBCF477-862D-4E02-9E27-9F076F81D59BQ88030045-8FEDF553-E670-4F74-B8E8-2F9A87DCED4EQ90725689-919C5D30-1EB0-42F9-A5A2-A171DF33A6EAQ91341790-DDB34EA5-24DA-4ECE-BA94-38FE857162C9Q91589812-5C06E982-DEBA-491E-B809-2484EA0FCA90Q91748945-A4EE424A-F384-4F15-8B13-43D76AC3E761Q92697960-0AA899AC-6C1A-4A05-BB5E-0239D60777F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Salwan Maqdasy
@ast
Salwan Maqdasy
@en
Salwan Maqdasy
@es
Salwan Maqdasy
@nl
Salwan Maqdasy
@sl
type
label
Salwan Maqdasy
@ast
Salwan Maqdasy
@en
Salwan Maqdasy
@es
Salwan Maqdasy
@nl
Salwan Maqdasy
@sl
prefLabel
Salwan Maqdasy
@ast
Salwan Maqdasy
@en
Salwan Maqdasy
@es
Salwan Maqdasy
@nl
Salwan Maqdasy
@sl
P106
P31
P496
0000-0001-5164-9879